No-Needle tetanus shot? new patch trial begins
NCT ID NCT07624669
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This first-in-human study tests a new microneedle patch (Miracus) that dissolves in the skin to deliver a tetanus vaccine without a needle. Thirty healthy adults will receive either an empty patch or one loaded with vaccine. Researchers will check safety, tolerability, and whether the patch triggers an immune response.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tetanus-containing vaccine
- What this could lead to
- If successful, this could lead to a pain-free way to deliver vaccines using a dissolving microneedle patch.
- What could go wrong
- This is a very early, small study (30 people) testing only safety and tolerability. It may not show that the patch delivers the vaccine effectively.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TETANUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new vaccine shield older kids and adults from three deadly infections?
- Can a Five-Part vaccine bolster protection against three serious infections?
- Can a single shot keep tetanus at bay?
- Will a single DTP vaccine dose protect for a decade? study tracks antibodies
- Can a new tetanus shot offer stronger protection?
- Are adults in beijing still protected against tetanus? a study investigates